Literature DB >> 162820

The pathology of Tangier disease. A light and electron microscopic study.

V J Ferrans, D S Fredrickson.   

Abstract

Tangier disease (deficiency of high density plasma lipoproteins) is characterized clinically by: low levels of plasma cholesterol; enlarged, orange-yellow to yellow-gray tonsils and, frequently, peripheral neuropathy. Histologic and ultrastructural studies were made of various tissues from 5 patients with Tangier disease, and comparisons were made of these findings with those in the 12 other patients thus far known to have this disease. Deposits of cholesteryl esters were found in: reticuloendothelial cells (foam cells) in tonsils, bone marrow, skin and jejunal submucosa; Schwann cells in peripheral nerves and myenteric plexus; and in nonvascular smooth muscle cells. These deposits appeared electron lucent and intensely birefringent, varied from spherical to crystalline in shape, often were extensively confluent throughout large areas of cytoplasm, and were not limited by membranes. Certain foam cells in bone marrow also contained membrane-limited clusters of lipid particles resembling chylomicrons. The foam cells in Tangier disease differ morphologically from those in numerous lysosomal enzyme deficiency states, particularly Wolman's disease and cholesteryl ester stroage disease, and in proliferative diseases of the reticuloendothelial system in which cholesteryl esters also accumulate in abnormal histiocytes. Morphologic and biochemical data suggest several hypotheses to explain the accumulation of cholesteryl esters in tissues of patients with Tangier disease. Among these hypotheses, the most likely are considered to be the presence in plasma of abnormal lipoprotein particles that are subject to phagocytic removal by reticuloendothelial cells, and the failure of a process that normally removes locally synthesized cholesterol from cells to plasma. (Am J Pathol 78:101-158, 1975)

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 162820      PMCID: PMC1915033     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  63 in total

1.  Hepatic cholesterol ester storage disease, a familial disorder. I. Clinical aspects.

Authors:  L Schiff; W K Schubert; A J McAdams; E L Spiegel; J F O'Donnell
Journal:  Am J Med       Date:  1968-04       Impact factor: 4.965

2.  Distribution of lesions in myenteric plexus and gastrointestinal mucosa in lipidoses and other neurologic disorders of children.

Authors:  S Kamoshita; B H Landing
Journal:  Am J Clin Pathol       Date:  1968-03       Impact factor: 2.493

3.  Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis).

Authors:  K Suzuki; G C Chen
Journal:  J Neuropathol Exp Neurol       Date:  1968-01       Impact factor: 3.685

4.  Wolman's disease.

Authors:  G C Guazzi; J J Martin; M Philippart; H Roels; H van der Eecken; L Vrints; M J Delbeke; C Hooft
Journal:  Eur Neurol       Date:  1968       Impact factor: 1.710

5.  Lipid studies in Wolman's disease.

Authors:  E C Kyriakides; N Filippone; B Paul; W Grattan; J A Balint
Journal:  Pediatrics       Date:  1970-09       Impact factor: 7.124

6.  Langerhans cells in a localized lesion of the eosinophilic granuloma type.

Authors:  A R Morales; G Fine; R C Horn; J H Watson
Journal:  Lab Invest       Date:  1969-05       Impact factor: 5.662

7.  Lymph node ultrastructure in Hand-Schüller-Christian disease.

Authors:  M Imamura; K Muroya
Journal:  Cancer       Date:  1971-04       Impact factor: 6.860

8.  Cutaneous lesions of Letterer-Siwe disease. Electron microscopic study.

Authors:  P A Cancilla; M E Lahey; W H Carnes
Journal:  Cancer       Date:  1967-11       Impact factor: 6.860

9.  Cutaneous cholesterol ester deposition in Tangier disease.

Authors:  D S Waldorf; R I Levy; D S Fredrickson
Journal:  Arch Dermatol       Date:  1967-02

10.  [Familial analphalipoproteinemia (Tangier disease)].

Authors:  H Kummer; J Laissue; H Spiess; R Pflugshaupt; U Bucher
Journal:  Schweiz Med Wochenschr       Date:  1968-03-16
View more
  41 in total

1.  Fatty liver: biochemical and clinical considerations.

Authors:  A M Hoyumpa; H L Greene; G D Dunn; S Schenker
Journal:  Am J Dig Dis       Date:  1975-12

2.  Wolman's disease: ultrastructural evidence of lipid accumulation in central and peripheral nervous systems.

Authors:  J C Byrd; J M Powers
Journal:  Acta Neuropathol       Date:  1979-01-12       Impact factor: 17.088

3.  Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase.

Authors:  G Assmann; P N Herbert; D S Fredrickson; T Forte
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

Authors:  G Assmann; E Smootz; K Adler; A Capurso; K Oette
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

5.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

6.  [Clinical and morphological findings in Tangier disease (hypo-alpha-lipoporteinaemia) and its ENT-significance (author's transl)].

Authors:  R Schröder; H Heckers
Journal:  Arch Otorhinolaryngol       Date:  1977-10-31

7.  Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthood. Report on two cases with remarks on the nature of the liver storage process.

Authors:  M Elleder; J Ledvinová; P Cieslar; R Kuhn
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

8.  [Tangier-disease (author's transl)].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1979-01-15

Review 9.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

10.  The storage lipids in Tangier disease. A physical chemical study.

Authors:  S S Katz; D M Small; J G Brook; R S Lees
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.